Currenc Group Inc CURR Q3 2025 Earnings EPS Surprises to the Upside Revenue Details Unavailable Power Integrations POWI Q1 2026 Earnings EPS Surpasses Estimates as Revenue Details Remain Undisclosed POR Q1 2026 Earnings EPS Misses Estimates by 346 as Cost Pressures Mount EZPW Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Acrivon Therapeutics Q1 2026 Earnings Narrower Loss Per Share as Pipeline Progress Continues Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip